Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study

Doravirine is a novel, highly potent, nonnucleoside reverse transcriptase inhibitor that is administered once daily and that is in development for the treatment of HIV-1 infection. In vitro and clinical data suggest that doravirine is unlikely to cause significant drug-drug interactions via major dr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Khalilieh, Sauzanne, Yee, Ka Lai, Sanchez, Rosa I., Triantafyllou, Ilias, Fan, Li, Maklad, Noha, Jordan, Heather, Martell, Maureen, Iwamoto, Marian
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278756/
https://ncbi.nlm.nih.gov/pubmed/27872071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01364-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars